Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques

被引:4
作者
Jairam, Vikram [1 ]
Pasha, Saamir [2 ]
Soulos, Pamela R. [2 ]
Gross, Cary P. [2 ,3 ,4 ]
Yu, James B. [1 ,2 ]
Park, Henry S. [1 ,2 ]
Decker, Roy H. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, 15 York St,Hunter Bldg,CB328, New Haven, CT 06511 USA
[2] Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res CO, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT USA
[4] Yale Univ, Sch Med, Natl Clinician Scholars Program, New Haven, CT USA
关键词
Radiation techniques; Post-operative radiotherapy; Toxicity; Non small cell; INTENSITY-MODULATED RADIOTHERAPY; ELDERLY-PATIENTS; STAGE-IIIA; PNEUMONITIS; PREDICTORS; SURVIVAL; ASSOCIATION;
D O I
10.1016/j.lungcan.2021.09.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Post-operative radiation therapy (PORT) in locally advanced non-small cell lung cancer (LA-NSCLC) has historically been associated with toxicity. Conformal techniques like intensity modulated radiation therapy (IMRT) have the potential to reduce acute and long-term toxicity from radiation therapy. Among patients receiving PORT for LA-NSCLC, we identified factors associated with receipt of IMRT and evaluated the association between IMRT and toxicity. Methods: We queried the Surveillance, Epidemiology, and End Results (SEER)-Medicare database between January 1, 2006 to December 31, 2014 to identify patients diagnosed with Stage II or III NSCLC and who received upfront surgery and subsequent PORT. Baseline differences between patients receiving 3-dimentional conformal radiation therapy (3D-CRT) and IMRT were assessed using the chi-squared test for proportions and the t-test for means. Multivariable logistic regression was used to identify predictors of receipt of IMRT and pulmonary, esophageal, and cardiac toxicity. Propensity-score matching was employed to reduce the effect of known confounders. Results: A total of 620 patients met the inclusion criteria, among whom 441 (71.2%) received 3D-CRT and 179 (28.8%) received IMRT. The mean age of the cohort was 73.9 years and 54.7% were male. The proportion of patients receiving IMRT increased from 6.2% in 2006 to 41.4% in 2014 (P < 0.001). IMRT was not associated with decreased pulmonary (OR 0.89; 95% CI, 0.62-1.29), esophageal (OR 1.09; 95% CI, 0.0.75-1.58), or cardiac toxicity (OR 1.02; 95% CI, 0.69-1.51). These findings held on propensity-score matching. Clinical risk factors including comorbidity and prior treatment history were associated with treatment toxicity. Conclusion: In a cohort of elderly patients, the use of IMRT in the setting of PORT for LA-NSCLC was not associated with a difference in toxicity compared to 3D-CRT. This finding suggests that outcomes from PORT may be independent of radiotherapy treatment technique.
引用
收藏
页码:171 / 179
页数:9
相关论文
共 50 条
  • [21] Comparison of 2 Common Radiation Therapy Techniques for Definitive Treatment of Small Cell Lung Cancer
    Shirvani, Shervin M.
    Juloori, Aditya
    Allen, Pamela K.
    Komaki, Ritsuko
    Liao, Zhongxing
    Gomez, Daniel
    O'Reilly, Michael
    Welsh, James
    Papadimitrakopoulou, Vassiliki
    Cox, James D.
    Chang, Joe Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (01): : 139 - 147
  • [22] Radiation Dose Escalation in Post-Operative Prostate Cancer Therapy Reply
    Gao, Xian-shu
    Qi, Xin
    Wang, Dian
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (04): : 1128 - 1128
  • [23] Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer
    Kim, Daniel W.
    Lee, Grace
    Lee, Hwan
    Qian, Jack M.
    Sanford, Nina N.
    Lam, Miranda B.
    Tahir, Naeem
    Mamon, Harvey J.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (03) : 516 - 521
  • [24] The effect of smoking status on survival following radiation therapy for non-small cell lung cancer
    Fox, JL
    Rosenzweig, KE
    Ostroff, JS
    [J]. LUNG CANCER, 2004, 44 (03) : 287 - 293
  • [25] The North American experience with stereotactic body radiation therapy in non-small cell lung cancer
    Timmerman, Robert D.
    Park, Clint
    Kavanagh, Brian D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (07) : S101 - S112
  • [26] Advances in stereotactic body radiation therapy for early stage non-small cell lung cancer
    Brown, Andrea M.
    Mak, Raymond H.
    Kann, Benjamin H.
    [J]. CURRENT CHALLENGES IN THORACIC SURGERY, 2022, 4
  • [27] Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer
    Jablonska, Paola Anna
    Bosch-Barrera, Joaquim
    Serrano, Diego
    Valiente, Manuel
    Calvo, Alfonso
    Aristu, Javier
    [J]. CANCERS, 2021, 13 (09)
  • [28] Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer
    Fujiwara, Masayuki
    Doi, Hiroshi
    Igeta, Masataka
    Suzuki, Hitomi
    Kitajima, Kazuhiro
    Tanooka, Masao
    Ishida, Toshihisa
    Wakayama, Tsukasa
    Yokoi, Takashi
    Kuribayashi, Kozo
    Kijima, Takashi
    Hashimoto, Masaki
    Kondo, Nobuyuki
    Matsumoto, Seiji
    Hasegawa, Seiki
    Kamikonya, Norihiko
    Yamakado, Koichiro
    [J]. ANTICANCER RESEARCH, 2021, 41 (11) : 5793 - 5802
  • [29] Stereotactic Body Radiation Therapy for Salvage Treatment of Recurrent Non-Small Cell Lung Cancer
    Kowalchuk, Roman O.
    Waters, Michael R.
    Richardson, K. Martin
    Spencer, Kelly M.
    Lamer, James M.
    Kersh, C. R.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2020, 10 (06) : E475 - E484
  • [30] Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC)
    Janssen, Stefan
    Kaesmann, Lukas
    Rudat, Volker
    Rades, Dirk
    [J]. ANTICANCER RESEARCH, 2016, 36 (02) : 825 - 828